Chad Spooner
First SEC filing: July 6, 2026 · Latest: July 6, 2026
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| July 28, 2026 | MMED | F | 23,301 | $17.67 | $411,729 | 362,707 Direct | -6.04% | Disposed | 11.5% (price as of 2026-10-02) |
| July 1, 2026 | MMED | A | 22,057 | · | · | 386,008 Direct | +6.06% | Acquired | (price as of 2026-10-02) |
| July 1, 2026 | MMED | A | 94,550 | · | · | 363,951 Direct | +35.10% | Acquired | (price as of 2026-10-02) |
| March 11, 2026 | MMED | A | 70,896 | · | · | 70,896 Direct | · | Acquired | (price as of 2026-10-02) |
| March 11, 2026 | MMED | A | 127,609 | · | · | 127,609 Direct | · | Acquired | (price as of 2026-10-02) |
| March 11, 2026 | MMED | A | 70,896 | · | · | 70,896 Direct | · | Acquired | (price as of 2026-10-02) |
| March 9, 2026 | MMED | A | 27,778 | · | · | 27,778 Direct | · | Acquired | (price as of 2026-10-02) |
| March 9, 2026 | MMED | A | 84,176 | · | · | 84,176 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| March 9, 2026 | MMED | Performance-Based Restricted Stock Units | Common Stock | · | · | 27,778 | Acquired |
| March 9, 2026 | MMED | Employee Stock Option (Right to Buy) | Common Stock | $18.00 | March 9, 2036 | 84,176 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2026 | $519,231 | $970,000 | $4,885,460 | $647,908 | · | · | $43,994 | $7,066,593 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.